CXCR4 and pancreatic ductal adenocarcinoma: Seo, Jiang (66) showed that pancreatic ductal adenocarcinoma cell killing within the slice was mediated by CTL activity following 6-days of combined PD-1 and C-X-C chemokine receptor type 4 (CXCR4) blockade.